Cargando…
Impact of Hypoxia–Hyperoxia Exposures on Cardiometabolic Risk Factors and TMAO Levels in Patients with Metabolic Syndrome
Along with the known risk factors of cardiovascular diseases (CVDs) constituting metabolic syndrome (MS), the gut microbiome and some of its metabolites, in particular trimethylamine-N-oxide (TMAO), are actively discussed. A prolonged stay under natural hypoxic conditions significantly and multi-dir...
Autores principales: | Bestavashvili, Afina, Glazachev, Oleg, Ibragimova, Shabnam, Suvorov, Alexander, Bestavasvili, Alexandros, Ibraimov, Shevket, Zhang, Xinliang, Zhang, Yong, Pavlov, Chavdar, Syrkina, Elena, Syrkin, Abram, Kopylov, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572339/ https://www.ncbi.nlm.nih.gov/pubmed/37833946 http://dx.doi.org/10.3390/ijms241914498 |
Ejemplares similares
-
Intermittent Hypoxic-Hyperoxic Exposures Effects in Patients with Metabolic Syndrome: Correction of Cardiovascular and Metabolic Profile
por: Bestavashvili, Afina, et al.
Publicado: (2022) -
The Effects of Intermittent Hypoxic–Hyperoxic Exposures on Lipid Profile and Inflammation in Patients With Metabolic Syndrome
por: Afina, A. Bestavashvili, et al.
Publicado: (2021) -
DUOX1 Gene Missense Mutation Confers Susceptibility on Type 2 Amiodarone-Induced Thyrotoxicosis
por: Biakina, Olga, et al.
Publicado: (2023) -
Effects of Intermittent Hypoxia-Hyperoxia Exposure Prior to Aerobic Cycling Exercise on Physical and Cognitive Performance in Geriatric Patients—A Randomized Controlled Trial
por: Behrendt, Tom, et al.
Publicado: (2022) -
Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial
por: Tuter, Denis S, et al.
Publicado: (2018)